Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,075Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pfizer Canada ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pfizer Canada ULC

arrow
CPHI Shenzhen
Not Confirmed

Pfizer Canada ULC

Country
arrow
CPHI Shenzhen
Not Confirmed

Abrocitinib

Brand Name : CIBINQO

Patent Number : 2900703

Filing Date : 2014-02-11

Strength per Unit : 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-02-11

Date Granted : 2017-11-28

blank

02

Pfizer Canada ULC

arrow
CPHI Shenzhen
Not Confirmed

Pfizer Canada ULC

Country
arrow
CPHI Shenzhen
Not Confirmed

Abrocitinib

Brand Name : CIBINQO

Patent Number : 2900703

Filing Date : 2014-02-11

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-02-11

Date Granted : 2017-11-28

blank

03

Pfizer Canada ULC

arrow
CPHI Shenzhen
Not Confirmed

Pfizer Canada ULC

Country
arrow
CPHI Shenzhen
Not Confirmed

Abrocitinib

Brand Name : CIBINQO

Patent Number : 2900703

Filing Date : 2014-02-11

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-02-11

Date Granted : 2017-11-28

blank